Phosphodiesterase inhibitors and cerebral vasospasm
Flamm, E.S.; Kim, J.; Lin, J.; Ransohoff, J.
Transactions of the American Neurological Association 99: 137-140
1974
ISSN/ISBN: 0065-9479 PMID: 4377047 Document Number: 75237
Document emailed within 1 workday
Related Documents
Nishizawa, Y. 1993: The pathogenesis and the preventive treatment of cerebral vasospasm following subarachnoid hemorrhage--especially clinical and pharmacological effect of Ca++ antagonist for vasospasm Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 389-396Barnette, M.S.; Manning, C.D.; Cieslinski, L.B.; Burman, M.; Christensen, S.B.; Torphy, T.J. 1995: The ability of phosphodiesterase IV inhibitors to suppress superoxide production in guinea pig eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activity Journal of Pharmacology and Experimental Therapeutics 273(2): 674-679
Niizuma, H.; Kwak, R.; Ohi, T.; Katakura, R.; Mizoi, K.; Suzuki, J. 1978: The angiographical study on cerebral vasospasm following the rupture of intracranial aneurysm (1st report).--Time relationship between vasospasm on angiography and the onset of subarachnoid hemorrhage (aurhor's transl) No Shinkei Geka. Neurological Surgery 6(8): 749-755
Sakaki, T.; Tanikake, T.; Kyoi, K.; Utsumi, S.; Kikuchi, H.; Oshima, M.; Hiasa, Y.; Murata, Y. 1980: A histopathological study of the brain of patients who died of cerebral vasospasm after rupture of cerebral aneurysm No Shinkei Geka. Neurological Surgery 8(9): 845-850
Majchrzak, H.; Lech, A.; Kopera, M.; Gajos, L.; Dragan, T.; Ladziński, P. 1995: Application of alteplase in prevention of cerebral vasospasm and its sequelae in patients after aneurysmal subarachnoid hemorrhage from ruptured cerebral aneurysm Neurologia i Neurochirurgia Polska 29(3): 379-387
Sarkis, A.; Pornin, M. 1990: Phosphodiesterase inhibitors Annales de Cardiologie et d'Angeiologie 39(7): 427-431
Miyagi, K.; Ishijima, B.; Sato, F.; Kubota, T.; Sakuraya, N. 1984: Indication for, the method of, and result of the prophylactic use of barbiturate therapy (B-therapy) against cerebral infarct from cerebral arterial vasospasm due to ruptured aneurysm No Shinkei Geka. Neurological Surgery 12(3 Suppl): 303-310
Corbin, J.D.; Francis, S.H. 2002: Pharmacology of phosphodiesterase-5 inhibitors International Journal of Clinical Practice 56(6): 453-459
Boldt, J.; Hammermann, H.; Hempelmann, G. 1994: Value of phosphodiesterase inhibitors in anesthesia and intensive care Zeitschrift für Kardiologie 83(Suppl 2): 75-82
Arbogast, R. 1993: Effects of phosphodiesterase inhibitors on diastolic function Archives des Maladies du Coeur et des Vaisseaux 86(Special Issue 2): 65-69
Scholz, H.; Dieterich, H.A.; Schmitz, W. 1991: Mechanism of the positive inotropic effect of phosphodiesterase inhibitors Zeitschrift für Kardiologie 80(Suppl 4): 1-6
Zuccarello, M. 2001: Endothelin: the "prime suspect" in cerebral vasospasm Acta Neurochirurgica. Suppl 77: 61-65
Haberl, R.L.; Villringer, A. 1990: Hypertensive-hypervolemic therapy in cerebral vasospasm Der Nervenarzt 61(12): 749-751
Türker, R.K.; Egemen, N.; Deda, H. 1989: Cerebral vasospasm: resolution by iloprost, nocloprost and UK 38 485 Progress in Clinical and Biological Research 301: 205-209
Sakai, T.; Okada, J.; Hara, M.; Ogashiwa, M.; Takeuchi, K. 1985: Red cell deformability in patients with cerebral vasospasm International Journal of Clinical Pharmacology Therapy and Toxicology 23(2): 79-82
Ono, S.; Date, I.; Ohmoto, T. 2001: Linkage of gene expression with cerebral vasospasm No Shinkei Geka. Neurological Surgery 29(7): 589-602
Giannotta, S.L.; McGillicuddy, J.E.; Kindt, G.W. 1977: Diagnosis and treatment of postoperative cerebral vasospasm Surgical Neurology 8(4): 286-290
Picard-Claret, M.; Melon, E.; Abhay, K.P.; Nguyen, J.P.; Gaston, A. 1989: Role of stopping calcium inhibitors in the worsening of postoperative vasospasm during the treatment of intracranial aneurysm Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 30(7): 441
Souness, J.E.; Foster, M. 1998: Potential of phosphodiesterase type of IV inhibitors in the treatment of rheumatoid arthritis Idrugs: the Investigational Drugs Journal 1(5): 541-553
Kulkarni, S.K.; Patil, C.S. 2004: Phosphodiesterase 5 enzyme and its inhibitors: update on pharmacological and therapeutical aspects Methods and Findings in Experimental and Clinical Pharmacology 26(10): 789-799